Toshiyuki Kamoto
Papers
4
Total Citations
30
H-Index
3
About
Toshiyuki Kamoto is a leading urologic surgeon and researcher whose work centers on advancing surgical outcomes for prostate and bladder cancers through large-scale, real-world data analysis. His major contributions lie in leveraging Japan’s National Clinical Database (NCD) Urology Division to provide the first detailed annual records on key urologic procedures, including robot-assisted radical prostatectomy (RARP) and radical cystectomy. His 2024 landmark study, with 15 citations, established foundational benchmarks for five common surgeries, while his subsequent analyses—such as evaluating thienopyridine antiplatelet effects on bleeding after RARP (7 citations) and comparing robot-assisted versus open cystectomy for muscle-invasive bladder cancer (5 citations)—offer critical safety insights. Kamoto has also reexamined the role of extended lymph node dissection in the RARP era, challenging conventional practices with real-world oncological data from over 8,000 patients. His work directly informs clinical decision-making, balancing surgical innovation with patient safety. With a growing citation impact and a focus on evidence-based urology, Kamoto is shaping the future of minimally invasive cancer surgery in Japan and beyond.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4